Home New Haven Press Releases 2011 East Haven Man Sentenced to Federal Prison for Role in Oxycontin Distribution Conspiracy
Info
This is archived material from the Federal Bureau of Investigation (FBI) website. It may contain outdated information and links may no longer function.

East Haven Man Sentenced to Federal Prison for Role in Oxycontin Distribution Conspiracy

U.S. Attorney’s Office December 09, 2011
  • District of Connecticut (203) 821-3700

David B. Fein, United States Attorney for the District of Connecticut, announced that DAVID DELOUGHERY, 44, of East Haven, was sentenced today by United States District Judge Stefan R. Underhill in Bridgeport to 12 months and one day of imprisonment, followed by three years of supervised release, for conspiring to distribute oxycontin.

According to court documents and statements made in court, for several years, DELOUGHERY used fraudulent prescriptions to purchase oxycontin from pharmacies. In 2008, DELOUGHERY and his mother, Maureen Gulianello, received money from Anthony “Terry” Buono of Wallingford to purchase oxycontin from pharmacies by using forged prescriptions. After purchasing the drugs, DELOUGHERY and Gulianello sold some of the pills for profit, repaid Buono the funds he had “fronted,” and also gave Buono a quantity of pills.

On October 14, 2009, DELOUGHERY pleaded guilty to one count of conspiracy to distribute oxycontin.

On February 4, 2011, Buono pleaded guilty to one count of conspiracy to possess with intent to distribute, and to distribute, oxycontin. On June 15, 2011, he was sentenced to 18 months of imprisonment and was ordered to forfeit $50,000 to the government.

On October 26, 2009, Gulianello, 69, of East Haven, pleaded guilty to one count of health care fraud for illegally selling oxycontin that had been paid for by the Medicare Program. On December 6, 2011, she was sentenced to 12 months and one day of imprisonment.

This matter was investigated by the Federal Bureau of Investigation, the Department of Health and Human Services, and the Food and Drug Administration. The case was prosecuted by Assistant United States Attorney Rahul Kale.

This content has been reproduced from its original source.